Phenotype switching and the melanoma microenvironment; impact on immunotherapy and drug resistance

HIGHLIGHTS

  • who: Sultana Mehbuba Hossain and Michael R. Eccles from the Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin , have published the research work: Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance, in the Journal: (JOURNAL)
  • what: While the 5-year survival rate is over 90% for localized melanoma, this drops to 16% for distant disease, indicating that metastasis is the main reason for poor outcomes . This model proposes a pro-proliferative role for MITF, driving an invasive to proliferative transition, but also, at very high MITF expression levels . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?